A Phase 1, Multi-Center, Open-Label, dose Escalation Study of Thrombosomes in Bleeding thrombocytopenic Patients in Three Cohorts | Clinical Trials | Health Care Professionals | Dartmouth-Hitchcock
Skip to main content
x
Dartmouth-Hitchcock logo
Summer Flowers In This Section
 
A Phase 1, Multi-Center, Open-Label, dose Escalation Study of Thrombosomes in Bleeding thrombocytopenic Patients in Three Cohorts
Principal Investigator (?)
Study Number
FED18023
Summary
This study evaluates in a dose-escalation manner, the safety, and preliminary impact on bleeding, and the preliminary effect on coagulation measures of increasing doses of allogeneic Thrombosomes in thrombocytopenic patients. 
Phase (?)
Phase III
Contact

Louise Marsh

Available at the following location(s)

Lebanon

View more details from ClinicalTrials.gov.

0